title: [The challenges of nanotechnology for the sanitary vigilance of medication].
abstract: The development of effective and safe nanotechnology medication with a high cost-benefit ratio is a strategic imperative for public health in Brazil. The lack of information demands sanitary regulation geared to protecting health and the environment. This study seeks to assess the current stage of development, the regulatory framework and the challenges facing nanotechnology medication in Brazil, emphasizing sanitary surveillance. Document analysis was conducted in national and international regulatory agency sites. Despite the incipient regulation for this type of medication, 7 registered nanotechnology products were found in Brazil, without clear identification on leaflets or packaging regarding their nanotechnology composition, as well as 4 similar products. Risk assessment and regulation of such medication requires specialized personnel and equipment, as well as the participation of society in the formulation and implementation of regulatory policies. The suggestion proposed is that the regulatory framework should follow the precautionary principle, whereby products are registered as new medication with clear information on the labeling and controlled usage, until further results on the assessment of risk are obtained.
authors.affiliation: Departamento de Administração e Planejamento em Saúde, Escola Nacional de Saúde Pública Sergio Arouca, Rio de Janeiro, RJ, Brasil, ariane.jesus@gmail.com.
authors.forename: Ariane de Jesus Sousa
authors.initials: Ade J
authors.lastname: Batista
authors.affiliation: Departamento de Administração e Planejamento em Saúde, Escola Nacional de Saúde Pública Sergio Arouca, Rio de Janeiro, RJ, Brasil, ariane.jesus@gmail.com.
authors.forename: Vera Lúcia Edais
authors.initials: VL
authors.lastname: Pepe
mesh_terms: D001938:Brazil; D017277:Drug Approval; D006801:Humans; D036103:Nanotechnology; D060735:Pharmacovigilance